A Clinico-Pathological Multidisciplinary Team Increases the Efficacy of Skin Biopsy and Reduces Clinical Risk in Dermatology

A clinical risk is an inherent risk in healthcare processes, including skin biopsy procedures, and may lead to misdiagnoses, increased healthcare costs and potential harm to patients. Indeed, clinical and histopathological data must be integrated if we are to reduce clinical risks and improve diagnostic accuracy in the diagnosis of dermatologic diseases. Although dermopathology services used to be part of a dermatologist’s duty, the recent centralization of these laboratories has caused a loss of expertise and increased both complexity and safety issues. Some countries have implemented clinical-pathological correlation programs aimed at facilitating communication between clinicians and dermatopathologists. However, Italy has regulatory and cultural barriers that make the implementation of these programs difficult. Therefore, an internal analysis was carried out to assess the efficacy and impact that skin biopsy procedures for inflammatory and neoplastic conditions have on the quality of care in our dermatology department. As the analysis evidenced a high number of descriptive pathologic reports and discordant diagnoses, a multidisciplinary group of four dermatologists, four general pathologists and one dermatopathologist was set up. Herein, we present the results of this analysis and project and describe the structure of the multidisciplinary group. We also discuss the pros and cons, possibilities and limitations of our project, including the regulatory barriers of the Italian National Health System.

[1]  K. Motaparthi,et al.  Impact of Skin Biopsy and Clinical-Pathologic Correlation in Dermatology Inpatient Consults , 2022, Cureus.

[2]  H. Feng,et al.  Cost-effectiveness of skin biopsies performed by non-physician clinicians for Medicare beneficiaries. , 2021, Dermatology online journal.

[3]  G. Hruza,et al.  Coronavirus Disease 2019 and Dermatology Practice Changes , 2021, Dermatologic Clinics.

[4]  James S. Taylor,et al.  Patient safety in dermatology: a ten-year update. , 2021, Dermatology online journal.

[5]  G. Argenziano,et al.  Second Diagnostic Opinion by Experienced Dermatopathologists in the Setting of a Referral Regional Melanoma Unit Significantly Improves the Clinical Management of Patients With Cutaneous Melanoma , 2021, Frontiers in Medicine.

[6]  C. Bogdan,et al.  Clinical Manifestation of Cutaneous Leishmaniasis Following a Mechanical Trauma , 2020, The international journal of lower extremity wounds.

[7]  C. Klersy,et al.  A significant reduction in the diagnosis of melanoma during the COVID‐19 lockdown in a third‐level center in the Northern Italy , 2020, Dermatologic therapy.

[8]  D. Elder,et al.  The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma: Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway. , 2020, Archives of pathology & laboratory medicine.

[9]  F. Elliott,et al.  Pathological review of primary cutaneous malignant melanoma by a specialist skin cancer multidisciplinary team improves patient care in the UK , 2019, Journal of Clinical Pathology.

[10]  M. Llamas-Velasco,et al.  Deceptively bland cutaneous angiosarcoma on the nose mimicking hemangioma—A clinicopathologic and immunohistochemical analysis , 2018, Journal of cutaneous pathology.

[11]  A. Amro,et al.  A pyoderma gangrenous-like cutaneous leishmaniasis in a Libyan woman with rheumatoid arthritis: a case report , 2018, BMC Research Notes.

[12]  A. Kennedy,et al.  Change Management , 2016 .

[13]  P. Cappelletti Il mutamento delle professioni della Medicina di Laboratorio , 2015, La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine.

[14]  J. Tilburt,et al.  Dermatopathologists' concerns and challenges with clinical information in the skin biopsy requisition form: a mixed‐methods study , 2015, Journal of cutaneous pathology.

[15]  A. Katsambas,et al.  Skin Biopsy in the Context of Dermatological Diagnosis: A Retrospective Cohort Study , 2014, Dermatology research and practice.

[16]  Alice J. Watson,et al.  Medical error in dermatology practice: development of a classification system to drive priority setting in patient safety efforts. , 2013, Journal of the American Academy of Dermatology.

[17]  Harald Kittler,et al.  Influence of evaluation of clinical pictures on the histopathologic diagnosis of inflammatory skin disorders. , 2010, Journal of the American Academy of Dermatology.

[18]  C. Price Roots, development and future directions of laboratory medicine , 2010, Clinical chemistry and laboratory medicine.

[19]  Doru Traian Alexandrescu,et al.  Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages. , 2009, Dermatology online journal.

[20]  C. Massone,et al.  Correction: The Influence of Clinical Information in the Histopathologic Diagnosis of Melanocytic Skin Neoplasms , 2009, PLoS ONE.

[21]  Cesare Massone,et al.  The Influence of Clinical Information in the Histopathologic Diagnosis of Melanocytic Skin Neoplasms , 2009, PloS one.

[22]  H. Kutzner,et al.  Optimierung der dermatopathologischen Diagnostik durch digitale Fotografie und Internet , 2007, Der Hautarzt.

[23]  Dermatopathology , 2007, Laboratory Investigation.

[24]  D. Troxel Medicolegal aspects of error in pathology. , 2006, Archives of pathology & laboratory medicine.

[25]  R. By,et al.  Organisational change management: A critical review , 2005 .

[26]  Frederick A Meier,et al.  Error detection in anatomic pathology. , 2005, Archives of pathology & laboratory medicine.

[27]  G. Beastall,et al.  A guide to defining the competence required of a consultant in clinical chemistry and laboratory medicine , 2005, Clinical chemistry and laboratory medicine.

[28]  Sandra C Hollensead,et al.  Errors in pathology and laboratory medicine: Consequences and prevention , 2004, Journal of surgical oncology.

[29]  H. Kerl,et al.  International Board Certification in Dermatopathology: paving the way for the future , 2004, The American Journal of dermatopathology.

[30]  H. Goldschmidt The NEXUS vision: an alternative to the reference value concept , 2004, Clinical chemistry and laboratory medicine.

[31]  D. Troxel,et al.  Pitfalls in the Diagnosis of Malignant Melanoma: Findings of a Risk Management Panel Study , 2003, The American journal of surgical pathology.

[32]  S. Nashef What is a near miss? , 2003, The Lancet.

[33]  J. Naeyaert,et al.  Inter‐observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions , 2002, The Journal of pathology.

[34]  B. Burnes Managing Change: A Strategic Approach to Organisational Dynamics , 2001 .

[35]  M. Feldman Organizational Routines as a Source of Continuous Change , 2000 .

[36]  T. Brennan,et al.  Incidence and types of adverse events and negligent care in Utah and Colorado. , 2000, Medical care.

[37]  H. Höfler,et al.  [The German Society of Pathology on the threshold of its second century]. , 1997, Der Pathologe.

[38]  Stanley J. Miller,et al.  Skin biopsy: Biopsy issues in specific diseases. , 2016, Journal of the American Academy of Dermatology.

[39]  A. Vannucci,et al.  Prevenire gli eventi avversi nella pratica clinica , 2013 .

[40]  Douglas H. Fernald,et al.  Evaluating the connections between primary care practice and clinical laboratory testing: a review of the literature and call for laboratory involvement in the solutions. , 2013, Archives of pathology & laboratory medicine.

[41]  E. Minelli,et al.  Change management: come vincere la sfida del cambiamento in azienda , 2007 .

[42]  William R. Hendee,et al.  To Err is Human: Building a Safer Health System , 2001 .

[43]  J. Reason Education and debate , 2000 .